9661
Compound 1 also displayed competitive behavior when assessed against the human GPR35 antagonist , ML - 145 ( 2 - hydroxy - 4 - [ 4 - ( 5Z ) - 5 - [ ( E ) - 2 - methyl - 3 - phenylprop - 2 - enylidene ] - 4 - oxo - 2 - sulfanylidene - 1 , 3 - thiazolidin - 3 - yl ] butanoylamino ] benzoic acid ) .
 ML - 145, 2 - hydroxy - 4 - [ 4 - ( 5Z ) - 5 - [ ( E ) - 2 - methyl - 3 - phenylprop - 2 - enylidene ] - 4 - oxo - 2 - sulfanylidene - 1 , 3 - thiazolidin - 3 - yl ] butanoylamino ] benzoic acid
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: Chemical 
Text: {0} 
Answer:
 ML - 145, 2 - hydroxy - 4 - [ 4 - ( 5Z ) - 5 - [ ( E ) - 2 - methyl - 3 - phenylprop - 2 - enylidene ] - 4 - oxo - 2 - sulfanylidene - 1 , 3 - thiazolidin - 3 - yl ] butanoylamino ] benzoic acid